Replies to post #157 on Evogene Ltd (EVGN)

[Fress]

Midas the sector is being brought down by the downgrade today by gene editing bell weather EDIT.


Morgan Stanley Downgrades Editas Medicine to Underweight, Lowers Price Target to $45 January 19, 2021


2021-01-19 11:42:00 GMT DJ Editas Medicine Price Target Cut to $45.00/Share From $64.00 by Morgan Stanley

almost 50% cut in the price of a company well funded with almost a half billion in cash.


could see the millions of shares hit the market at any time from the 28 million dollar raise last week.

EVGN From their SEC filing, looks like the offering will be made at $5.22.

"Assuming that an aggregate of 5,363,984 shares are sold at a price of $5.22 per share, the last reported sale price of our ordinary shares on Nasdaq on January 12, 2021."



This sucks holding 100k shares market futures are surging and the where down. going back to sleep.


$EVGN